Stay updated on Rilzabrutinib for CSU: H1 Resistant - Clinical Trial
Sign up to get notified when there's something new on the Rilzabrutinib for CSU: H1 Resistant - Clinical Trial page.

Latest updates to the Rilzabrutinib for CSU: H1 Resistant - Clinical Trial page
- Check7 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5 for the page, indicating a minor update to the ClinicalTrials.gov entry. There is no indication that study content or eligibility criteria were modified.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedA new revision label, v3.5.4, has been added to the page, replacing the previous v3.5.3. This change serves as a metadata/versioning update and does not modify the study content presented on the page.SummaryDifference0.0%

- Check50 days agoChange DetectedThe page’s footer site revision was updated from v3.5.2 to v3.5.3, reflecting a website software release rather than any modification to the clinical trial information.SummaryDifference0.0%

- Check57 days agoChange DetectedRevision v3.5.2 was added and revision v3.5.0 was removed.SummaryDifference0.0%

- Check87 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.0%

- Check101 days agoChange DetectedAdded a revision notice: Revision: v3.4.3, and removed Revision: v3.4.2.SummaryDifference0.0%

Stay in the know with updates to Rilzabrutinib for CSU: H1 Resistant - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rilzabrutinib for CSU: H1 Resistant - Clinical Trial page.